39 related articles for article (PubMed ID: 19303138)
1. Recent advances in the systemic treatment of gastrointestinal stromal tumors.
Jones RL; Golčić M
Cancer Biol Med; 2023 Oct; 20(10):701-5. PubMed ID: 37874125
[No Abstract] [Full Text] [Related]
2. Momelotinib Dihydrochloride.
Am J Health Syst Pharm; 2024 Jan; 81(1):e1-e3. PubMed ID: 37862456
[No Abstract] [Full Text] [Related]
3. Hypertrophic cardiomyopathy as a high-risk feature on perioperative care: How to deal with this self-fulfilling prophecy?
Bichuette LD; Lottenberg MP; Caramelli B
Int J Cardiol; 2024 Mar; 399():131683. PubMed ID: 38158137
[No Abstract] [Full Text] [Related]
4. KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors.
Lai S; Wang G; Cao X; Luo X; Wang G; Xia X; Hu J; Wang J
Oncotarget; 2016 Jan; 7(2):1367-79. PubMed ID: 26587973
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Tumor Recurrence in Patients with Non-Gastric Gastrointestinal Stromal Tumors Following Resection according to the Modified National Institutes of Health Criteria.
Jang SH; Kwon JE; Kim JH; Lee JY; Kim SG; Kim JS; Jung HC; Im JP
Intest Res; 2014 Jul; 12(3):229-35. PubMed ID: 25349597
[TBL] [Abstract][Full Text] [Related]
6. Cyclin H expression is increased in GIST with very-high risk of malignancy.
Dorn J; Spatz H; Schmieder M; Barth TF; Blatz A; Henne-Bruns D; Knippschild U; Kramer K
BMC Cancer; 2010 Jul; 10():350. PubMed ID: 20598140
[TBL] [Abstract][Full Text] [Related]
7. Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors.
Blay JY; Pérol D; Le Cesne A
Ann Oncol; 2012 Jul; 23(7):1659-65. PubMed ID: 22357253
[TBL] [Abstract][Full Text] [Related]
8. The SSG XVIII/AIO trial: results change the current adjuvant treatment recommendations for gastrointestinal stromal tumors.
Eisenberg BL
Am J Clin Oncol; 2013 Feb; 36(1):89-90. PubMed ID: 23334483
[TBL] [Abstract][Full Text] [Related]
9. [Indications for pre- and postoperative treatment with imatinib for gastrointestinal stromal tumors].
Heger U; Weitz J; Lordick F
Chirurg; 2008 Jul; 79(7):630-7. PubMed ID: 18548219
[TBL] [Abstract][Full Text] [Related]
10. 'Time is a GIFT in GIST'--the medical and paramedical perspective of a case with metastatic gastrointestinal stromal tumor.
Sevinc A; Camci C
Chemotherapy; 2009; 55(1):11-4. PubMed ID: 18974643
[TBL] [Abstract][Full Text] [Related]
11. That's the "GIST" of it: use of adjuvant imatinib after resection of a primary GI stromal tumor.
Tap WD; Schwartz GK
J Clin Oncol; 2014 May; 32(15):1543-6. PubMed ID: 24638004
[No Abstract] [Full Text] [Related]
12. Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
Joensuu H; Eriksson M; Hall KS; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Ballman KV; Leinonen M; DeMatteo RP; Reichardt P
Cancer; 2014 Aug; 120(15):2325-33. PubMed ID: 24737415
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant imatinib in GIST: a self-fulfilling prophecy, or more?
Hohenberger P
Lancet; 2009 Mar; 373(9669):1058-60. PubMed ID: 19303138
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
